PF-03550096
Product Specifications
UNSPSC Description
PF-03550096 is an orally active synthetic cannabinoid (CB) that selectively targets peripheral CB2 receptors with a Ki value of 7.9 nM. PF-03550096 has analgesic activity[1].
Target Antigen
Cannabinoid Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein;Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/pf-03550096.html
Solubility
10 mM in DMSO
Smiles
O=C(N1C2=CC=CC=C2N(CCC(C)(O)C)C1=O)N[C@H](C(N)=O)C(C)(C)C
Molecular Weight
376.45
References & Citations
[1]Kikuchi A, et al. Pharmacological evaluation of a novel cannabinoid 2 (CB2) ligand, PF-03550096, in vitro and in vivo by using a rat model of visceral hypersensitivity. J Pharmacol Sci. 2008 Feb;106(2):219-24.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-129787/PF-03550096-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-129787/
Clinical Information
No Development Reported
CAS Number
910376-39-5
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![7- (Chloromethyl) benzo[d]thiazole](https://cdn.genprice.uk/genprice/genprice5.png)
![7- (Chloromethyl) benzo[d]thiazole](https://cdn.genprice.uk/genprice/genprice4.png)
